CAGRISEMA 10mg (Cagrilintide 5mg + Semaglutide 5mg) [Dual weight-loss blend] – Hudson Science

Description

CAGRISEMA 10MG (CAGRILINTIDE 5MG + SEMAGLUTIDE 5MG) – HUDSON SCIENCE

CagriSema by Hudson Science is a synergistic peptide formulation combining Cagrilintide (5MG) and Semaglutide (5MG) in a single 10MG vial, designed to deliver amplified weight loss, appetite suppression, and metabolic enhancement through dual-pathway activation.

Cagrilintide is an amylin receptor agonist that promotes satiety and reduced food intake, while Semaglutide is a GLP-1 receptor agonist that enhances insulin sensitivity, glycemic control, and appetite regulation. Together, they create a powerful combo that mimics natural hormonal processes to support body recomposition, fat reduction, and energy balance.

Each lyophilized vial contains:

• 5MG Cagrilintide – Amylin mimetic for prolonged satiety
• 5MG Semaglutide – GLP-1 agonist for glucose and appetite control
• Total: 10MG of clinical-grade peptide blend

This combination is ideal for those conducting advanced research on obesity, metabolic disorders, and appetite-modulating therapies.

For more advanced peptides and blends, visit: True North Performance